Elevation Oncology Shares Outstanding vs. Return On Equity
| ELEV Stock | USD 0.61 0.01 1.67% |
For Elevation Oncology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Elevation Oncology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Elevation Oncology utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Elevation Oncology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Elevation Oncology over time as well as its relative position and ranking within its peers.
Elevation |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevation Oncology. If investors know Elevation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevation Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.25) | Return On Equity (0.64) |
The market value of Elevation Oncology is measured differently than its book value, which is the value of Elevation that is recorded on the company's balance sheet. Investors also form their own opinion of Elevation Oncology's value that differs from its market value or its book value, called intrinsic value, which is Elevation Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevation Oncology's market value can be influenced by many factors that don't directly affect Elevation Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevation Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevation Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevation Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Elevation Oncology Return On Equity vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Elevation Oncology's current stock value. Our valuation model uses many indicators to compare Elevation Oncology value to that of its competitors to determine the firm's financial worth. Elevation Oncology is rated # 3 in shares outstanding category among its peers. It is rated # 2 in return on equity category among its peers . At this time, Elevation Oncology's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Elevation Oncology by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Elevation Return On Equity vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Elevation Oncology |
| = | 59.12 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Elevation Oncology |
| = | -0.64 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Elevation Return On Equity Comparison
Elevation Oncology is currently under evaluation in return on equity category among its peers.
Elevation Oncology Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Elevation Oncology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Elevation Oncology will eventually generate negative long term returns. The profitability progress is the general direction of Elevation Oncology's change in net profit over the period of time. It can combine multiple indicators of Elevation Oncology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 9 K | 9.4 K | |
| Operating Income | -45.4 M | -47.7 M | |
| Income Before Tax | -45.7 M | -48 M | |
| Total Other Income Expense Net | -229 K | -240.4 K | |
| Net Loss | -85.6 M | -81.3 M | |
| Net Loss | -45.7 M | -48 M | |
| Income Tax Expense | 30 K | 31.5 K | |
| Net Loss | -56.8 M | -59.7 M | |
| Net Interest Income | -300 K | -315 K | |
| Interest Income | 3.9 M | 2.7 M | |
| Non Operating Income Net Other | -455.4 K | -478.2 K | |
| Change To Netincome | 4 M | 4.2 M | |
| Net Loss | (1.34) | (1.41) | |
| Income Quality | 1.23 | 0.75 | |
| Net Income Per E B T | 1.00 | 0.80 |
Elevation Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Elevation Oncology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Elevation Oncology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Elevation Oncology's important profitability drivers and their relationship over time.
Use Elevation Oncology in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elevation Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will appreciate offsetting losses from the drop in the long position's value.Elevation Oncology Pair Trading
Elevation Oncology Pair Trading Analysis
The ability to find closely correlated positions to Elevation Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elevation Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elevation Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elevation Oncology to buy it.
The correlation of Elevation Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elevation Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elevation Oncology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elevation Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Elevation Oncology position
In addition to having Elevation Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Biotech Thematic Idea Now
Biotech
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.